1 NID 2 and HOXA 9 promoter hypermethylation as biomarkers for prevention and early detection in Oral Cavity Squamous Cell Carcinoma tissues and saliva

@inproceedings{GuerreroPreston20111N2,
  title={1 NID 2 and HOXA 9 promoter hypermethylation as biomarkers for prevention and early detection in Oral Cavity Squamous Cell Carcinoma tissues and saliva},
  author={Guerrero-Preston and Soudry and Javier Acero and Orera and Moreno-L{\'o}pez and Mac{\'i}a-Col{\'o}n and Germ{\'a}n and Berdasco and Ili-Gangas and Brebi-Mieville and Irizarry and Esteller and Westra and Koch and Joseph A. Califano and Sidransky},
  year={2011}
}
  • Guerrero-Preston, Soudry, +13 authors Sidransky
  • Published 2011
Differentially methylated oral squamous cell carcinoma (OSCC) biomarkers, identified in-vitro and validated in well-characterized surgical specimens, have shown poor clinical correlation in cohorts with different risk profiles. To overcome this lack of relevance we used the HumanMethylation27 BeadChip, publicly available methylation and expression array… CONTINUE READING